Author + information
- Received May 22, 2020
- Accepted June 1, 2020
- Published online July 15, 2020.
- Sandra Zendjebil, MD,
- Michel Zeitouni, MD,
- Marc Batonga, MD,
- Nathan El Bèze, MD,
- Paul Guedeney, MD,
- Jean-Philippe Collet, MD, PhD,
- Rémi Choussat, MD,
- Johanne Silvain, MD, PhD and
- Gilles Montalescot, MD, PhD∗ (, )@ActionCoeur
- ACTION (Allies in Cardiovascular Trials Initiatives and Organized Networks) Study Group, Sorbonne Université, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, Paris, France
- ↵∗Address for correspondence:
Prof. Gilles Montalescot, ACTION Study Group, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, 47-83 Bd de l'Hôpital, 75013 Paris, France.
A 42-year-old man was admitted for an ST-segment elevation myocardial infarction revealing an acute thrombosis of the left anterior descending and right coronary arteries. Following this acute multivessel coronary occlusion in a young individual at low cardiovascular risk, he tested positive for severe acute respiratory syndrome-coronavirus-2 infection. (Level of Difficulty: Beginner.)
This study was led by the ACTION Study Group at the Institute of Cardiology of Pitié-Salpêtrière Hospital. Dr. Zeitouni has received research grants from Institut Servier and Fédération Française de Cardiologie and BMS/Pfizer. Dr. Silvain has received research grants from Amed, Amgen, Algorythm, AstraZeneca, Bayer, Daiichi-Sankyo, Eli Lilly, Fondation de France, Gilead Science, Iroko Cardio, Sanofi-Aventis, and St. Jude Medical. Dr. Montalescot has received research grants from Abbott, Amgen, Actelion, AstraZeneca, Bayer, Boehringer Ingelheim, Boston-Scientific, Bristol-Myers Squibb, Beth Israel Deaconess Medical, Brigham Women’s Hospital, Cardiovascular Research Foundation, Daiichi-Sankyo, Idorsia, Lilly, Europa, Elsevier, Fédération Française de Cardiologie, ICAN, Medtronic, Journal of the American College of Cardiology, Lead-Up, Menarini, Merck Sharp & Dohme, Novo-Nordisk, Pfizer, Sanofi, Servier, The Mount Sinai School, TIMI Study Group, and WebMD. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Case Reports author instructions page.
- Received May 22, 2020.
- Accepted June 1, 2020.
- 2020 The Authors